Company news
Helix BioPharma Corp. news in 2007
Helix BioPharma Corp.'s news releases, calls and decks from 2007, newest first.
Helix BioPharma closes $16.9 million private placement of common shares
December 19, 2007
Helix BioPharma announces Q1 2008 financial results
December 17, 2007
Helix BioPharma announces $16.9 million private placement of common shares
December 17, 2007
Helix BioPharma Corp. announces management changes
November 15, 2007
Helix BioPharma Corp. announces fiscal 2007 results
October 26, 2007
Helix BioPharma Chairman resigns
October 15, 2007
Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
October 11, 2007
Helix BioPharma awarded U.S. Patent for DOS47 adjunct chemotherapy applications
September 17, 2007
Helix BioPharma announces Q3 2007 financial results
June 13, 2007
Helix BioPharma awarded first U.S. Patent for DOS47
May 3, 2007
Helix BioPharma Corp. announces positive phase II clinical results with its Topical Interferon Alpha-2b
April 2, 2007
Helix BioPharma Announces Q2 2007 Financial Results
March 8, 2007
Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy
March 5, 2007
Helix BioPharma to Present L-DOS47 Lung Cancer Research Findings at Keystone Symposia Meeting in Lake Louise, Alberta
February 1, 2007
2007 - A Pivotal Year for Helix
January 18, 2007
International Penta has not fully disclosed the nature of its Helix share position
January 16, 2007
Helix BioPharma Corp. responds to Penta's January 13, 2007 press release
January 15, 2007
Helix BioPharma Corp. responds to Penta's January 11, 2007 press release
January 12, 2007
ISS Recommends Helix Shareholders Vote "FOR" Management's Slate of Directors and Private Placement
January 11, 2007
Helix BioPharma Corp. responds to dissident proxy circular
January 10, 2007
Helix BioPharma Corp. signs L-DOS47 manufacturing agreement with BioVectra dcl
January 5, 2007